Generics 80

Originals

Biosimilars

Medical devices

Nutraceuticals 2

Filters

L-ornithine l-aspartate manufacturers

80 products found

Filters

80 products found

l-ornithine l-aspartate + magnesium aspartate tetrahydrate

Sachets 5 g + 2.4 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Manufacturer #17481
One of the biggest pharmaceutical giants who are known to be delivering first-quality pharmaceutical solutions for an extended period. The line of business includes pharmaceutical manufacturing, fabricating, and processing of drugs for both human as well as veterinary usage.

Manufacturer usually replies in 8 days

l-ornithine l-aspartate

Concentrate for solution for infusion 500 mg/ml - 10 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Ukraine
GMP approvals
EU GMP
Unavailable markets
Algeria , Bahrain , Djibouti , Egypt , Iran , Iraq , Jordan , Kuwait , Lebanon , Libya , Morocco , Oman , Palestinian Territory , Qatar , Saudi Arabia , Syria , Tunisia , United Arab Emirates , Yemen
Comments
This product doesn’t fit requirements of EU
Manufacturer #15907
A world leader in the production and maintenance of medicines as well as a leading exporter with a proven track record of exporting to more than 40 countries. High quality and constant innovation have proven to be the biggest achiever here.

Manufacturer usually replies in 8 days

l-ornithine l-aspartate

Sachets 3 g, 5 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Ukraine
GMP approvals
EU GMP
Unavailable markets
Vietnam
Comments
OTC
Manufacturer #15907
A world leader in the production and maintenance of medicines as well as a leading exporter with a proven track record of exporting to more than 40 countries. High quality and constant innovation have proven to be the biggest achiever here.

Manufacturer usually replies in 8 days

l-ornithine l-aspartate

Ampoules, injection 5 g/10 ml - 10 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS, EU GMP
Manufacturer #2272
The company integrates and applies enormous experience and technology in the field of hospital products. Their goal is to become a global leader in intensive care units and maintain that position. The company's headquarters were established in Europe in 1980ies, and serum production was continuing in a plant in Europe till the end of the 2000s. With a nationwide market share of 50%, it has become one of the leading serum producers. They've already started making the first ready-to-use injections.

Manufacturer usually replies in 7 days

l-ornithine l-aspartate

Injection 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21177

Manufacturer usually replies in 12 days

l-ornithine l-aspartate

Injection 5 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20847

Manufacturer usually replies in 6 days

l-ornithine l-aspartate

Injection 5 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
Indonesia
Manufacturer #20700

Manufacturer usually replies in 5 days

l-ornithine l-aspartate

Solution for infusion 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
Indonesia
Manufacturer #20656

Manufacturer usually replies in 2 days

l-ornithine l-aspartate

Injection 5000 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19861

Manufacturer usually replies in 3 days

l-ornithine l-aspartate + pancreatin

Tablets 150 mg+100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19740

Manufacturer usually replies in 1 days

l-ornithine l-aspartate

Injection 5 gm

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19740

Manufacturer usually replies in 1 days

l-ornithine l-aspartate + pancreatin

Tablets 150 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19124

Manufacturer usually replies in 2 days

l-ornithine l-aspartate

Injection 5 g/ 10 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18273

Manufacturer usually replies in 1 days

l-ornithine l-aspartate

Injection 5 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18174

Manufacturer usually replies in 4 days

l-ornithine l-aspartate + pancreatin

Tablets 150 mg + 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18161

Manufacturer usually replies in 2 days

l-ornithine l-aspartate + silymarin

Tablets 250mg + 140mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #8293
It is one of the fastest-growing pharmaceutical companies in the European continent. It started its operation in the 2000s. It is committed to providing high-quality infrastructure to the most striving individuals throughout the country who dream to make it big.

Manufacturer usually replies in 2 days

l-ornithine l-aspartate + pancreatin

Tablets 150mg + 100mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #8293
It is one of the fastest-growing pharmaceutical companies in the European continent. It started its operation in the 2000s. It is committed to providing high-quality infrastructure to the most striving individuals throughout the country who dream to make it big.

Manufacturer usually replies in 2 days

l-ornithine l-aspartate

Concentrate for solution for infusion 500 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Ukraine
GMP approvals
Ukraine
Manufacturer #16213
The company's history stretches back to the 1990s when it began producing infusion solutions. By accumulating influence and experience in the sector, a newly founded company began its activities in the Eastern European pharmaceutical market with minimal production capacity. The company's strategy was shaped by the economic situation in the pharmaceutical market at the time, expanding corporate competition, and the need for future development.

Manufacturer usually replies in 3 days

l-ornithine l-aspartate

Ampoules, injection 5g/10ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
South Korea
Manufacturer #8104
It was established in the late 1950s. It has been making significant efforts to protect the healthy lives of human beings by producing a variety of treatments starting with injection Products. The company operates its business for various customers including business clients, patients, pharmacists, and doctors. They are trying to make their supply chain more effective to provide the necessary medicines faster.

Manufacturer usually replies in 4 days

l-ornithine l-aspartate

Solution for injection 5 g - 10 ml

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
China
Manufacturer #12677

Manufacturer usually replies in 4 days

Want to view all 80 products? Create your free account today!

L-ornithine L-aspartate Manufacturers

L-ornithine L-aspartate is a medicine for people with advanced liver disease with reduced brain function. Research conducted on L-ornithine-L-aspartate efficacy showed that it can reduce symptoms of reducing brain function in people with a liver disease called cirrhosis. However, L-ornithine-L-aspartate might not help control symptoms hepatic encephalopathy, which were caused by some other reason. L-ornithine-L-aspartate also helps improve athletic performance. L-ornithine-L-aspartate is a combination of two amino acids, ornithine and aspartic acid. While the body uses amino acids as building blocks to make protein, L-ornithine L-aspartate is not used to make protein. The human body instead brakes it down in to get ornithine and aspartic acid. Merz pharma in Germany first filed for a patent and was granted around 2010. Evonik industries and some Japanese companies have also filed for patents for different preparations of these medicines. Most frequently prescribed for impaired brain function in adults with severe liver disease (hepatic encephalopathy). There isn't any solid scientific data to back up its usage for cirrhosis, enhancing athletic performance, or any other conditions. According to research, administering L-ornithine-L-aspartate orally or intravenously to cirrhotic patients may lower their risk of passing away. However, not all studies concur. To determine whether L-ornithine-L-aspartate can benefit those who have cirrhosis, more research is required. If administered intravenously, L-ornithine-L-aspartate is possibly safe. Some patients receiving injections of L-ornithine-L-aspartate have experienced nausea, vomiting, coughing, muscle cramps, and diarrhoea. But these adverse consequences are uncommon.

Forms and Dosage

L-ornithine L-aspartate is sold in several forms like rapid melt granules, tablets and injection. In patients with advanced liver disease, the recommended daily dose for tablets is 9-18 grams for up to 3 months. Injection for the same comes with a recommended adult dose of 5-40 grams for up to 7 days.

How does L-ornithine L-aspartate work?

LOLA is what is known as a stable salt of the two constituent amino acids, L-ornithine and L-aspartate. L-ornithine stimulates the urea cycle finally resulting in loss of ammonia. L-ornithine L-aspartate actions lower blood ammonia levels and increase the levels of ornithine and aspartic acid in the body. Ammonia is then used to convert glutamate to glutamine by glutamine synthetase. As both a l-ornithine and l-aspartate are both substrates for glutamate transaminase, LOLA administration can result in increased glutamate levels. Ornithine and aspartic acid levels in the body are raised by L-ornithine L-aspartate. These amino acids aid in lowering blood levels of the poisonous toxin ammonia.

The Cost of L-ornithine L-aspartate

An online search for the wholesale price for sale of L-ornithine L-aspartate for distributors will reveal a wide range of costs. It will vary from store to store depending on your visit and the country of the wholesale market. The consumer in the USA has to pay USD 70 for a supply of 100g of L-ornithine-L-aspartate. The cost of this medicine varies widely in the developing world, as can be seen in India, where the same supply of 100g will cost between $7-$70.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of L-ornithine L-aspartate distributors offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and this substance L-ornithine L-aspartate suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of L-ornithine L-aspartate. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where L-ornithine L-aspartate is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical product deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers L-ornithine L-aspartate suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen L-ornithine L-aspartate Manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.